MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$2,883K
Free Cash flow
-$2,938K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Prepaid expenses
Accrued expenses
Issuance cost of common stock up...
Others
Negative Cash Flow Breakdown
Net loss
Change in fair value of common w...
Accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-2,911
-3,521
-2,941
-2,912
Stock-based compensation expense
570
317
285
349
Non-cash lease expense
34
23
88
-
Noncash lease expense
-
-
-
23
Change in fair value of common warrants classified as a liability
-351
97
-506
-175
Depreciation expenses
5
1
1
-1
Loss on disposition of assets
-2
-
-
-
Accounts receivable
200
141
-30
126
Inventory
4
190
-83
272
Prepaid expenses
-186
177
-112
-80
Other current assets
-45
-19
158
-143
Other non current assets
200
-
-
-
Accounts payable
-206
254
-70
198
Accrued expenses
163
-391
121
103
Net cash used in operating activities
-2,867
-3,709
-3,020
-2,270
Purchase of property and equipment
71
0
0
0
Net cash used in investing activities
-71
0
0
0
Gross proceeds from equity financing
-
-
-
12,102
Proceeds from common stock and pre-funded common stock warrants
0
10,000
12,102
-
Issuance cost of common stock upon private placement
-55
953
0
1,299
Proceeds from exercise of common warrants
0
-
0
0
Proceeds from exercise of stock options
0
0
0
0
Net cash provided by financing activities
55
9,047
0
0
Net increase in cash and cash equivalents
-2,883
5,338
-3,020
-2,270
Beginning of period
12,362
7,024
10,044
7,154
End of period
9,479
12,362
7,024
10,044
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Issuance cost of common
stock upon private...
-$55K
Net cash provided by
financing activities
$55K
(-99.49%↓ Y/Y)
Net increase in cash
and cash...
-$2,883K
(-155.87%↓ Y/Y)
Canceled cashflow
$55K
Stock-based compensation
expense
$570K
(-9.95%↓ Y/Y)
Prepaid expenses
-$186K
(-282.35%↓ Y/Y)
Accrued expenses
$163K
(133.33%↑ Y/Y)
Other current assets
-$45K
(-200.00%↓ Y/Y)
Non-cash lease expense
$34K
Depreciation expenses
$5K
(150.00%↑ Y/Y)
Loss on disposition
of assets
-$2K
Net cash used in
operating activities
-$2,867K
(49.55%↑ Y/Y)
Net cash used in
investing activities
-$71K
(-3450.00%↓ Y/Y)
Canceled cashflow
$1,005K
Net loss
-$2,911K
(45.23%↑ Y/Y)
Purchase of property and
equipment
$71K
(3450.00%↑ Y/Y)
Change in fair value of
common warrants...
-$351K
(-50.00%↓ Y/Y)
Accounts payable
-$206K
(-342.35%↓ Y/Y)
Other non current
assets
$200K
Accounts receivable
$200K
(-37.50%↓ Y/Y)
Inventory
$4K
Buy us a coffee
RenovoRx, Inc. (RNXT)
RenovoRx, Inc. (RNXT)